Pfizer, BioNTech ask FDA to approve use of vaccine in children ages 12 to 15
Published
Pfizer and BioNTech requested Friday that the U.S. Food and Drug Administration grant emergency use approval to start administering the COVID-19 vaccine to children ages 12 to 15.
Full Article